Newmark has completed the $8.8 million sale of a single-tenant, 21,000-square-foot dialysis clinic fully occupied on an absolute, triple-net lease basis by Fresenius Medical Care. With over 3,900 locations, Fresenius is the leading dialysis clinic in the United States, and this asset, located at 1809 West Chapman Avenue in Orange, CA, is one of its flagship Southern California locations.
Newmark’s Senior Managing Directors Glenn Rudy and Rob Ippolito represented the seller, Orange County-based Adray Plaza, LLC. The buyer, a Southern California-based family trust, who was in a 1031 exchange, was represented by Matthew Graham of Graham & Associates.
“This asset is adjacent to the Platinum Triangle of Anaheim which is the most active area per capita for residential/mixed use development in all of Orange County, and subsequently has been attractive to capital investment,” said Rudy. “Newmark’s Retail Capital Markets team has been active in this submarket over the last 24 months with a total of eight properties either sold, currently in escrow, or on the market now.”
Originally built in 1988 with a complete renovation in 2016 to meet Fresenius’ specifications, the asset is situated on 1.63 acres. 1809 West Chapman is well-located less than half a mile east of State Route 57 and benefits from 350 feet of frontage along Chapman Avenue. It is also less than a mile from world-renowned U.C. Irvine Medical Center, St Joseph Hospital and CHOC Children’s Hospital as well as leading educational campuses Azusa Pacific and Chapman Universities.
Rudy summarized, “Given the long-term, net lease structure; strong credit tenancy; and favorable, infill location, this asset presents the new ownership with a safe, secure cash-flowing investment that is hard to replicate in today’s Orange County market.”
Newmark (“Newmark”), operated by Newmark Group, Inc. (“Newmark Group”) (NASDAQ: NMRK), is one of the world’s leading and most trusted commercial real estate advisory firms, offering a complete suite of services and products for both owners and occupiers. Together with London-based partner Knight Frank and independently-owned offices, Newmark’s 16,000 professionals operate from approximately 430 offices on six continents. Newmark’s investor/owner services and products include investment sales, agency leasing, property management, valuation and advisory, diligence, underwriting, government-sponsored enterprise lending, loan servicing, debt and structured finance and loan sales. Occupier services and products include tenant representation, real estate management technology systems, workplace and occupancy strategy, global corporate services consulting, project management, lease administration and facilities management. For further information, visit www.ngkf.com. Newmark Group is a publicly traded subsidiary of BGC Partners, Inc. (“BGC”) (NASDAQ: BGCP), a leading global brokerage company servicing the financial and real estate markets.
Discussion of Forward-Looking Statements about Newmark
Statements in this document regarding Newmark that are not historical facts are “forward-looking statements” that involve risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements. Except as required by law, Newmark undertakes no obligation to update any forward-looking statements. For a discussion of additional risks and uncertainties, which could cause actual results to differ from those contained in the forward-looking statements, see Newmark’s Securities and Exchange Commission filings, including, but not limited to, the risk factors and Special Note on Forward-Looking Information set forth in these filings and any updates to such risk factors and Special Note on Forward-Looking Information contained in subsequent reports on Form 10-K, Form 10-Q or Form 8-K.